EDIT vs ELV · rev $32.3M vs P/E 18, rev $199.13B
Editas Medicine Inc (EDIT) versus Elevance Health Inc (ELV) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Elevance Health Inc (ELV) is a healthcare plans company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported ELV revenue for 2025-12-31 was $199.13B. Net income was $5.66B. Revenue was up 12.5% from 2024-12-31 to 2025-12-31. ELV currently screens at market cap $90.24B and trailing P/E 17.6.
EDIT currently screens at market cap $375.2M. ELV currently screens at market cap $90.24B and trailing P/E 17.6.
Not investment advice. Open the EDIT and ELV stock pages for the full models.
Not investment advice.